Amy Yang is currently the Sr. Director of Inspection Intelligence at Bayer, where they manage inspections for pharmaceutical and consumer health products and have been instrumental in securing over 15 NDA approvals in two years. Previously, they held various roles in clinical trial management and regulatory affairs, gaining extensive experience in cardiovascular and anti-infectives. Amy earned a Bachelor of Science in Biochemistry and Molecular Biology from Sichuan University and a Master of Science in Pharmaceutical Sciences from China Pharmaceutical University. Their career spans over two decades in the pharmaceutical industry, contributing significantly to clinical and regulatory processes.
This person is not in the org chart
This person is not in any teams
This person is not in any offices